Psyence Biomedical (PBM) EBT (2023 - 2025)

Psyence Biomedical's EBT history runs 3 years deep, the most recent figure standing at -$1.5 million for Q3 2025.

• On a quarterly basis, EBT fell 230.18% year-over-year to -$1.5 million in Q3 2025; TTM through Sep 2025 was -$3.8 million, a N/A change from a year earlier, with the FY2026 full-year figure at -$6.2 million, down 70.34% from the prior year.
• EBT eased to -$1.5 million in Q3 2025 per PBM's latest filing, from $1.2 million in the prior quarter.
• Across five years, EBT topped out at $1.2 million in Q3 2024 and bottomed at -$3.2 million in Q1 2023.
• The 3-year median for EBT is -$840571.0 (2023), against an average of -$939977.2.
• Across the five-year window, EBT surged 756.26% in 2024 and tumbled 230.18% in 2025, its largest moves.
• Year by year, EBT stood at -$176165.0 in 2023, then jumped by 756.26% to $1.2 million in 2024, then tumbled by 230.18% to -$1.5 million in 2025.
• Per Business Quant, the three latest PBM EBT figures stand at -$1.5 million (Q3 2025), $1.2 million (Q3 2024), and -$176165.0 (Q3 2023).